4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-001215
Options or other derivatives
- Pres. Research & Development acquired 1,813,133 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Young David Pres. Research & Development | 2025-07-24 | Grant or award · Restricted Stock Units | +1,813,133 | 1,821,016 | D | ||
Loading xslF345X05/form4.xml…